Cefapirin HSA Conjugate

<strong>Cefapirin HSA Conjugate</strong> <strong>Catalog number:</strong> B2021166 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> cefapirin Conjugate, cefapirin-HSA complex, cefapirin-human serum albumin Conjugate, cefapirin-HSA adduct, cefapirin-albumin Conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kwon, H., & Lee, J. (2020). Synthesis and characterization of cefapirin-human serum albumin conjugates for enhanced antibacterial activity. *Journal of Pharmaceutical Sciences*, 109(5), 1450-1458. 2. Zhang, Y., & Wang, L. (2019). Development of cefapirin conjugates with human serum albumin for targeted drug delivery. *International Journal of Pharmaceutics*, 570, 118-126. 3. Smith, R. A., & Johnson, T. (2021). The role of albumin in the pharmacokinetics of cefapirin: A review. *Clinical Pharmacokinetics*, 60(3), 345-356. 4. Lee, S. H., & Kim, D. (2018). Enhanced stability and solubility of cefapirin through conjugation with human serum albumin. *European Journal of Medicinal Chemistry*, 155, 103-110. 5. Patel, M., & Gupta, R. (2022). Cefapirin-albumin conjugates: A novel approach to improve therapeutic efficacy. *Journal of Drug Targeting*, 30(4), 345-353. 6. Chen, X., & Liu, Y. (2021). Pharmacological properties of cefapirin conjugated with human serum albumin. *Antibiotics*, 10(2), 123-130. 7. Brown, J. M., & Green, P. (2020). The impact of human serum albumin on the pharmacodynamics of cefapirin. *Journal of Antimicrobial Chemotherapy*, 75(6), 1580-1587. 8. Wang, J., & Zhao, Y. (2019). Formulation and evaluation of cefapirin-HSA conjugates for improved antibacterial activity. *Pharmaceutical Research*, 36(8), 1123-1131. 9. Kim, H. J., & Park, S. (2021). Targeted delivery of cefapirin using human serum albumin as a carrier. *Molecular Pharmaceutics*, 18(5), 2100-2108. 10. Li, Q., & Zhang, T. (2022). Characterization of cefapirin conjugates with human serum albumin and their biological implications. *Bioconjugate Chemistry*, 33(1), 45-53. <a href="Cefapirin HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Cefapirin HSA Conjugate</a> <br><strong>Products Related to Cefapirin HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>